Age | ||
Median | 60 years | |
Range | 32-88 years | |
n | % | |
Karnofsky performance status | ||
30-70% | 40 | 29.6% |
80-90% | 95 | 70.3% |
Histology | ||
Invasive ductal | 107 | 79.3% |
Invasive lobular | 28 | 20.7% |
Receptor status positivity | ||
ER (N = 34) | 28 | 82.4% |
PgR (N = 50) | 40 | 80.0% |
HER2 (N = 135) | 39 | 28.9% |
Site | ||
Thoracic | 99 | 73.3% |
Lumbar | 36 | 26.7% |
Number of bone metastases | ||
Solitary | 59 | 43.7% |
Multiple | 76 | 56.3% |
Treatment indications | ||
Pain | 69 | 51.1% |
Instability | 44 | 32.6% |
Pathological fracture | ||
Before RT | 29 | 21.5% |
After RT | 8 | 5.9% |
Surgical corset | ||
During RT | 82 | 60.7% |